Wall Street is often blamed for reducing corporate managers’ understanding of business to a single, gameable measure of ...

Private-equity executives entered 2025 with high hopes for a dealmaking recovery that is lifting payouts to fund investors ...

Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

With private asset ETFs still awaiting regulatory approval, opportunistic issuers are continuing to crank out products that ...

As private equity continues to shape the Irish M&A landscape, experts predict strong activity in the coming years, fueled by ...

Chinese companies are tapping into a rebound in investor sentiment fueled by hopes of Beijing's support for private firms and ...

Record revenues from management fees and a brighter outlook for M&A in the year ahead helped private equity's Big Four close 2024 on a high note.

Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the program to discuss two recent reports exploring the impacts of private equity on the US health care system.

Focus Healthcare Partners, which focuses on senior living assets, has purchased a bankrupt New York property for $86 million.

Wojcicki and New Mountain have offered to acquire all of 23andMe's outstanding shares in cash for $2.53 per share, or an ...

Baby Boomers are "the luckiest generation" in America and the most entitled in recent history, how did they get so lucky?